Target intelligence / Profile preview

Myofascial tissue mobility

Molecular classification
Other
01

Overview

Myofascial tissue mobility refers to the ability of the muscle and its enveloping fascial layers to glide and shift relative to one another during physiological movement. This property is primarily governed by the state of the extracellular matrix (ECM), particularly the concentration and viscosity of hyaluronic acid (HA) located in the loose connective tissue between fascial planes (Stecco et al., 2011, PubMed). When HA becomes 'densified' or polymerized, it increases the friction between layers, leading to stiffness, restricted range of motion, and the development of myofascial pain syndrome (Pavan et al., 2014, PubMed). Although 'mobility' is a functional state rather than a specific molecular receptor, it is influenced by drugs such as hyaluronidase, which breaks down HA to restore gliding, or muscle relaxants and botulinum toxins that reduce the active tension transmitted through the fascia (NIH, StatPearls). Maintaining adequate myofascial mobility is critical for efficient force transmission and the prevention of chronic musculoskeletal disorders.

Other names
Fascial glidingSoft tissue mobilityMyofascial slidingFascial displacementTissue compliance
02

Mechanism of action

Enzymatic hydrolysis of hyaluronic acid or collagen to reduce extracellular matrix viscosity and adhesions, or inhibition of neuromuscular transmission to decrease mechanical tension in the myofascial unit.

03

Biological functions

Force transmissionProprioceptionTissue glidingStructural supportMetabolic exchange
04

Disease associations

Myofascial pain syndromeFibromyalgiaChronic low back painAdhesive capsulitisScar tissue/Adhesions
05

Safety considerations

Anaphylaxis to exogenous enzymes (e.g., hyaluronidase)Risk of bruising or hematoma from local injectionsTemporary muscle weakness following neuromuscular blockadePotential for excessive tissue laxity
06

Interacting drugs

Hyaluronidase

4 more in the full profile.

07

Biomarkers

Shear wave elastographyMyotonometry (tissue stiffness)Range of motion (ROM)Pressure pain threshold (PPT)Dynamic ultrasound imaging (gliding distance)

Beyond the preview

Go deeper on Myofascial tissue mobility.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myofascial tissue mobility.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call